Previous diagnoses and medications Out of all 45,326 incident patients included within the entire period, 85.8% had at least one of the selected cardiovascular and metabolic diagnoses recorded in primary care or hospitals during 5 years before being dispensed their first GLP-1 RA, whereas 14.2% had not been given any of these diagnoses (Fig
A modified microdosing approach uses doses between 0.5 mg and 2.0 mg weekly
Staying hydrated, improving your sleep hygiene, maintaining a balanced diet, and engaging in regular exercise may help to minimize fatigue
Patel A, MacMahon S, Chalmers J et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
Most users report noticing significant changes around the 4-6 week mark, with continued improvements over 3-6 months of consistent use